نتایج جستجو برای: rosuvastatin

تعداد نتایج: 1991  

2018
STEFAN CHIORESCU OCTAVIAN AUREL ANDERCOU NICOLAE OVIDIU GRAD ION AUREL MIRONIUC

Objectives The purpose of this experimental study was to demonstrate the reduction of peritoneal adhesions formation in rats after intraperitoneal administration of rosuvastatin, due to its anti-inflammatory effect. Method Peritoneal adhesions were induced in 120 Wistar-Bratislava rats divided into 4 groups (n=30), using a parietal and visceral (cecal) abrasion model. Group I was designated a...

2014
Oktay Burma Ayhan Uysal Elif Onat Engin Sahna Necip Ilhan Deniz Erol Mete Ozcan

AIM Endothelial dysfunction, oxidative stress and inflammation are among the most important mechanisms of ischaemia-reperfusion (I/R) injury. Besides their cholesterol-lowering effects, statins are known to provide protection against myocardial dysfunction and vascular endothelial injury via nitric oxide-dependent mechanisms. The aim of this study was to investigate the effects of rosuvastatin ...

2016
Hayder M. Al-Kuraishy Ali I. Al-Gareeb

BACKGROUND Adiponectin is an important adipocyte-related protein that has been postulated to participate in prevention of the development of metabolic syndrome. The relationship between adiponectin serum levels and risk of coronary artery disease (CAD) has been widely investigated and remains controversial. The aim of the present study was to evaluate the effects of rosuvastatin and/or omega-3 ...

2005
Liyue Huang Yi Wang Scott Grimm

A list of nonstandard abbreviations used in the paper: ABC, ATP-binding cassette Abstract MDR1/ABCB1, MRP2/ABCC2 and BCRP/ABCG2 are expressed in the liver and intestine and contribute to the disposition of many drugs. Rosuvastatin, an HMG-CoA reductase inhibitor for the treatment of patients with dyslipidemia, is primarily excreted via bile as unchanged drug. The present study was designed to d...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2018
Masashi Uchida Yoriko Tajima Masakazu Kakuni Yutaka Kageyama Taro Okada Eri Sakurada Chise Tateno Ryoji Hayashi

The influence of transporters on the pharmacokinetics of drugs is being increasingly recognized, and DDIs via transporters may be a risk factor for adverse events. Cyclosporine A, a strong OATP inhibitor, has been reported to increase the systemic exposure of rosuvastatin, an OATP substrate, by 7.1-fold in clinical studies. PXB mice are chimeric mice with humanized livers that are highly repopu...

Journal: :International journal of cardiology 2013
Micaela Gliozzi Ross Walker Saverio Muscoli Cristiana Vitale Santo Gratteri Cristina Carresi Vincenzo Musolino Vanessa Russo Elzbieta Janda Salvatore Ragusa Antonio Aloe Ernesto Palma Carolina Muscoli Franco Romeo Vincenzo Mollace

BACKGROUND Statins are the most commonly prescribed drugs to reduce cardiometabolic risk. Besides the well-known efficacy of such compounds in both preventing and treating cardiometabolic disorders, some patients experience statin-induced side effects. We hypothesize that the use of natural bergamot-derived polyphenols may allow patients undergoing statin treatment to reduce effective doses whi...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014
Nicholas T Funderburg Ying Jiang Sara M Debanne Norma Storer Danielle Labbato Brian Clagett Janet Robinson Michael M Lederman Grace A McComsey

BACKGROUND Statins, or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, have anti-inflammatory effects that are independent of their lipid-lowering properties. Despite suppressive antiretroviral therapy (ART), elevated levels of immune activation and inflammation often persist. METHODS The Stopping Atherosclerosis and Treating Unhealthy Bone With Rosuvastatin in HIV (SATU...

Journal: :Joint, bone, spine : revue du rhumatisme 2013
Pietro Enea Lazzerini Caterina Capperucci Adriano Spreafico Pier Leopoldo Capecchi Silvia Niccolini Paolo Ferrata Bruno Frediani Mauro Galeazzi Franco Laghi-Pasini

OBJECTIVE Experimental and clinical data suggest that statins may protect bone by inhibiting bone resorption and/or stimulating bone formation. Interleukin-6 (IL-6) is produced by osteoblasts, and potently stimulates osteoclast activation playing a key role in normal bone resorption as well as in post-menopausal and inflammation-driven osteoporosis. Although statins inhibit IL-6 production from...

2012
Kathryn A. Radigan Daniela Urich Alexander V. Misharin Sergio E. Chiarella Saul Soberanes Angel Gonzalez Harris Perlman Richard G. Wunderink G. R. Scott Budinger Gökhan M. Mutlu

RATIONALE HMG-CoA reductase inhibitors such as rosuvastatin may have immunomodulatory and anti-inflammatory effects that may reduce the severity of influenza A infection. We hypothesized that rosuvastatin would decrease viral replication, attenuate lung injury, and improve mortality following influenza A infection in mice. METHODS C57Bl/6 mice were treated daily with rosuvastatin (10 mg/kg/da...

2016
Ji Hoe Heo Dongbeom Song Hyo Suk Nam Eung Yeop Kim Young Dae Kim Kyung-Yul Lee Ki-Jeong Lee Joonsang Yoo Youn Nam Kim Byung Chul Lee Byung-Woo Yoon Jong S. Kim

BACKGROUND AND PURPOSE The benefit of statins in acute stroke remains uncertain. Statins may prevent stroke recurrence during the acute stage of stroke via pleiotropic effects. However, statins may increase the risk of intracerebral hemorrhage. We investigated the effect and safety of rosuvastatin in acute stroke patients. METHODS This randomized, double-blind, multi-center trial compared ros...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید